MedTrace Logo

Precision Immunology to Determine the Immune Response in Patients With COVID-19

NCT04360733 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-05-05

No results posted yet for this study

Summary

To better understand the immune response to SARS-CoV-2 infection, we devised a precision immunology approach to systematically study the immune function of different patient cohorts

Conditions

Interventions

OTHER

Blood draw

serial blood draw and subsequent deep immune phenotyping analysis, (ii.) immune activation assays, (iii.) transcriptome and (iv.) epigenome analysis in an overarching (v.) bioinformatics data analysis

Sponsors & Collaborators

  • University of Bonn

    lead OTHER

Principal Investigators

  • Eicke Latz, Prof · Institute of Innate Immunity, Univeristy of Bonn

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-20
Primary Completion
2022-04-30
Completion
2022-09-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04360733 on ClinicalTrials.gov